首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Saravanasingh Karan Chand Mohan Singh,Sugumaran Pichamuthu,V Gowri et al. Saravanasingh Karan Chand Mohan Singh et al.
Pachaieruvai comprises five ingredients recognized for their cytotoxic properties, including arsenic trioxide and copper sulfate, which may assist in targeting abnormal cell growth.
Xionghui Wang,Simo Cheng,Yannan Xu et al. Xionghui Wang et al.
Background: Hepatocellular carcinoma (HCC) remains a major global health challenge, with limited efficacy of current immunotherapeutic strategies. Immunogenic cell death (ICD), characterized by the release of damage-assoc...
Yue Fei,Guang Yun Lai,Jun Wang Yue Fei
A healthy 4-year-old Chinese girl visited the clinic with an unhealed gingival wound and alveolar bone exposure of the missing primary molar area after 1-day arsenic trioxide sealing during pulp therapy. Radiographic examinations indicated inflammation and sequestrum formation in the jaw.
Lemchukwu C Amaeshi,Yusuf Adelabu,Olufunto Kalejaiye Lemchukwu C Amaeshi
Treatment initiation with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) was delayed due to the unavailability of the medication locally and, therefore, had to be ordered from a different country.
Ao Zhang,Shaowei Qiu Ao Zhang
The introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has significantly improved the complete remission rate in APL, making it a highly treatable disease.
Han Wang,Zixi Yun,Yuan Cao et al. Han Wang et al.
The clinical significance of our findings is threefold: we establish PML1 as a biomarker for therapy resistance, demonstrate its mechanistic role in treatment failure, and show that FDA-approved arsenic trioxide can disrupt PML1-driven resistance....These insights provide a direct path to clinical translation, as combining arsenic trioxide with existing therapies could benefit patients with limited treatment options.
Patricia L Kropf,Woonbok Chung,Raji Shameem et al. Patricia L Kropf et al.
Preclinical studies have indicated that arsenic trioxide (ATO) and carboplatin (Carbo) enhance DAC's epigenetic gene derepression. Consequently, we initiated a randomized phase 2 clinical trial evaluating DAC alone, or with Carbo or ATO, in patients with MDS/AML.
Meiling Zhang,Shupeng Chen,Yaru Cui et al. Meiling Zhang et al.
Current research suggests that arsenic trioxide (Arsenic Trioxide, ATO) can regulate autophagy and upregulate NKG2D ligands (NKG2D-L) on the surface of AML cells, while the NKG2D-NKG2D-L axis is negatively associated with AML immune evasion.
Nungruthai Nilsri,Rujira Mekchaaum,Supaporn Kalasin et al. Nungruthai Nilsri et al.
Interferon α2a (IFN-α2a) and arsenic trioxide were also administered to the cells to explore their potential effects. The JAK2 V617F-mutated cells were found to exhibit a higher level of JAK2 gene expression compared with the wild type....Furthermore, the treatments with IFN-α2a and arsenic trioxide led to the preferential suppression of the cell proliferation rate of the K562 expressing mutant JAK2 cells compared with the wild type cells, and this suppression occurred in a dose-dependent manner(p < 0.01).
Md Mizanur Rahman,Md Habibur Rahman,Md Arju Hossain et al. Md Mizanur Rahman et al.
Prospective chemical substances such as tretinoin, valproic acid, and arsenic trioxide have been predicted to be linked to cardiomyopathy treatment. The acceptable value of receiver operating characteristic (ROC) curve analysis revealed that biomarkers play critical roles in cardiomyopathy.
耗时 0.10196 秒,为您在 48229835 条记录里面共找到 3606 篇文章 [XML]